Surgical intervention for patients with stage IV-A hepatocellular carcinoma without lymph node metastasis: Proposal as a standard therapy

Annals of Surgery

Volumn 227, Issue 3, 1998, Pages 433-439

  Ikai, Iwao ^a   Yamaoka, Yoshio ^a   Yamamoto, Yuzo ^a   Ozaki, Nobuhiro ^a   Sakai, Yoshiharu ^a   Satoh, Seiji ^a   Shinkura, Niobuhiko ^a   Yamamoto, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; FEMALE; HEPATIC VEIN; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; SURVIVAL RATE;

EID: 0031911767     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199803000-00016     Document Type: Article

References (35)

1. Livraghi T, Giorgio A, Marin G, et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
2. Yamada R, Kishi K, Sato M, et al. Transcatheter arterial chemoembolization (TACE) in the treatment of unresectable liver cancer. World J Surg 1995; 19:795-800.
3. Takayasu K, Wakao F, Moriyama N, et al. Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors. Hepatology 1992; 16:906-911.
4. Mazzaferro V, Regalia E, Dogi R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334:693-699.
5. Mori K, Ozawa K, Yamamoto Y, et al. Response of hepatic mitochondrial redox state to oral glucose load-redox tolerance test as a new predictor of surgical risk in hepatectomy. Ann Surg 1990; 211:438-446.
6. Ozawa K, Aoyama H, Yasuda K, et al. Metabolic abnormalities associated with postoperative organ failure. Arch Surg 1983; 118: 1245-1251.
7. Takayasu K, Moriyama N, Muramatsu Y, et al. The diagnosis of small hepatocellular carcinomas: efficacy of various imaging procedures in 100 patients. AJR 1990; 155:49-54.
8. Yamaoka Y, Ozawa K, Tanaka A, et al. New device for harvesting a hepatic graft from a living donor. Transplantation 1991; 52:157-160.
9. Kumada K, Ozawa K, Okamoto R, et al. Hepatic resection for advanced hepatocellular carcinoma with removal of the portal vein tumor thrombi. Surgery 1990; 180:821-827.
10. Yamaoka Y, Ozawa K, Shimahara Y, et al. Simple and direct approach to the portal triad structure for a left lobectomy or a left lateral segmentectomy. Surg Gynecol Obstet 1988; 166:78-80.
11. Yamaoka Y, Ozawa K, Kumada K, et al. Total vascular exclusion for hepatic resection in cirrhotic patients. Arch Surg 1992; 127:276-280.
12. Kumada K, Shimahara Y, Fukui K, et al. Extended right hepatic lobectomy: combined resection of inferior vena cava and its reconstruction by ePTFE graft (Gore-Tex). Acta Chir Scand 1988; 154:481-483.
13. Kiuchi T, Ozawa K, Yamamoto Y, et al. Changes in arterial ketone body ratio in the phase immediately after hepatectomy. Arch Surg 1990; 125:655-659.
14. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Ann Surg 1990; 211:277-287.
15. UICC International Union Against Cancer. In Hermanek P. Sobin LH, eds. TNM Classification of Malignant Tumors, 4th ed. Berlin: Springer-Verlag; 1987:53-55.
16. Une Y, Misawa K, Shimamura T, et al. Treatment of lymph-node recurrence in patients with hepatocellular carcinoma. Surg Today 1994; 24:606-609.
17. Yamamoto M, Sugahara K. Overview of the general rules for the clinical and pathological study of primary liver cancer in Japan. In Tobe T, Kameda H, Okudaira M, et al. eds. Primary Liver Cancer in Japan. Tokyo: Springer-Verlag; 1992:385-392.
18. Healey JE Jr, Schroy PC. Anatomy of the biliary ducts within the human liver: analysis of the prevailing pattern of branching and the major variations of biliary duct. Arch Surg 1953; 66:599-616.
19. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan. Sixth report. Cancer 1987; 60:1400-1411.
20. The Liver Cancer Study Group of Japan. Predictive factors for long-term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. Cancer 1994; 74:2772-2780.
21. Schwartz ME, Sung M, Mor E, et al. Multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 1995; 180:596-603.
22. Shimada M, Takenaka K, Kawahara N, et al. Surgical treatment strategy for patients with Stage IV hepatocellular carcinoma. Surgery 1996; 119:517-522.
23. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991; 15:270-285.
24. Iwatsuki S, Starzl TE, Sheahan DG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991; 214:221-229.
25. Yasui M, Harada A, Torii A, et al. Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg 1995; 19:439-443.
26. Tsuda H, Hirohashi S, Shimosato Y, et al. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma. Gastroenterology 1988; 95:1664-1666.
27. Sugihara M, Nakashima O, Kojiro M, et al. The morphologic transition in hepatocellular carcinoma. Cancer 1992; 70:1488-1492.
28. Yamamoto Y, Mogaki M, Matsuda M, Matsumoto Y. A possible prototype of multifocal recurrence after liver resection of hepatocellular carcinoma: report of a case. Surg Today 1993; 23:830-835.
29. Vauthey JN, Klimstra D, Franceschi D, et al. Factors affecting long-term outcome after hepatic resection for hepatocellular carcinoma. Am J Surg 1995; 169:28-35.
30. Akashi Y, Koreeda S, Enomoto S, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariable analysis of 90 cases. Hepatology 1991; 14:262-268.
31. Calvet X, Bruix J, Gines, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology 1990; 12:753-760.
32. Okada S, Okazaki N, Nose H, et al. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Hepatology 1992; 16:112-117.
33. Raoul J, Guyader D, Bretagne J, et al. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support. J Nucl Med 1994; 35:1782-1787.
34. Nagasue N, Yukaya H, Ogawa Y, et al. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery 1986; 99: 694-701.
35. Fan S, Lai ECS, Lo C, et al. Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis. Arch Surg 1995; 130:198-203.